From clinical trials to regulatory submission, stop managing by spreadsheet. Start leading with intelligence built by people who understand your science.
The same data foundations and applied AI that power the largest drug makers, built for how your science actually works.
Pharma and biotech generate massive volumes of data across clinical, regulatory, and commercial operations. Most organizations can't connect the dots fast enough to make decisions that matter.
Trial data, regulatory submissions, and commercial intelligence live in separate systems. Connecting them is where the value is, and where the time goes.
Trial data, real-world evidence, and post-market surveillance live in separate systems. Connecting them for signal detection or submission readiness takes months, not days.
FDA, EMA, and global regulatory bodies demand faster, cleaner submissions. Manual data reconciliation creates risk at every step of the pipeline.
Drug launch analytics, payer intelligence, and market access data are fragmented across vendors. Your commercial teams are flying blind when they should be leading with insight.
Site performance tracking, patient enrollment forecasting, and protocol deviation detection, giving clinical operations the visibility to act before timelines slip.
End-to-end pipeline visibility from discovery through commercialization. Track milestones, resource allocation, and competitive landscape in real time.
Automated submission readiness, audit trail management, and global regulatory alignment. Reduce the manual burden of compliance without sacrificing rigor.
Lab data integration, research spend optimization, and collaboration analytics. Turn R&D from a cost center into a data-driven competitive advantage.
Unified view of trial data across sites and phases. Predictive enrollment models, real-time safety signal monitoring, and automated CDISC-ready data preparation.
Continuous submission readiness scoring, gap analysis, and document lineage tracking. Prepare for inspections and submissions without the last-minute scramble.
Market access intelligence, payer landscape mapping, and launch performance tracking. Understand formulary positioning and competitive dynamics before your competitors do.
Integrate claims data, EHR feeds, and patient registries into a unified evidence platform. Support label expansion, HEOR studies, and post-market commitments with clean data.
BioPharma42 is currently under development and testing.
We're building BioPharma42 with the same rigor we bring to every North Labs solution, embedded with domain experts, validated with real data, and designed to deliver measurable outcomes from day one. Coming soon.
We run advisory-led engagements in data and AI. Industry subject matter experts act as your trusted advisors. Forward-deployed engineers embed inside your organization and work as a hybrid of engineer, consultant, and product manager. They learn how you operate, then design, build, and run the systems in production.
Industry subject matter experts sit with your team and find the work worth doing.
They embed in your organization as engineer, consultant, and product manager in one, and build alongside your people.
We get data and AI into production and keep it running. Demos are easy. Production is the job. We believe this is the delivery model for the future of business. It is how industrials and the mid-market reach their full impact, on the economy and on people's lives.
Bring us a single clinical, regulatory, or commercial decision. We will pressure test it with you.